1. Home
  2. KLXE vs SCLX Comparison

KLXE vs SCLX Comparison

Compare KLXE & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • SCLX
  • Stock Information
  • Founded
  • KLXE 2018
  • SCLX 2011
  • Country
  • KLXE United States
  • SCLX United States
  • Employees
  • KLXE N/A
  • SCLX N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • SCLX Health Care
  • Exchange
  • KLXE Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • KLXE 35.8M
  • SCLX 33.9M
  • IPO Year
  • KLXE N/A
  • SCLX N/A
  • Fundamental
  • Price
  • KLXE $2.00
  • SCLX $5.30
  • Analyst Decision
  • KLXE Hold
  • SCLX Strong Buy
  • Analyst Count
  • KLXE 1
  • SCLX 3
  • Target Price
  • KLXE $4.50
  • SCLX $367.50
  • AVG Volume (30 Days)
  • KLXE 268.5K
  • SCLX 125.0K
  • Earning Date
  • KLXE 08-06-2025
  • SCLX 08-12-2025
  • Dividend Yield
  • KLXE N/A
  • SCLX N/A
  • EPS Growth
  • KLXE N/A
  • SCLX N/A
  • EPS
  • KLXE N/A
  • SCLX N/A
  • Revenue
  • KLXE $688,600,000.00
  • SCLX $50,710,000.00
  • Revenue This Year
  • KLXE N/A
  • SCLX $107.00
  • Revenue Next Year
  • KLXE $3.97
  • SCLX $82.52
  • P/E Ratio
  • KLXE N/A
  • SCLX N/A
  • Revenue Growth
  • KLXE N/A
  • SCLX 7.79
  • 52 Week Low
  • KLXE $1.51
  • SCLX $3.60
  • 52 Week High
  • KLXE $7.66
  • SCLX $78.05
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 45.93
  • SCLX 49.86
  • Support Level
  • KLXE $1.86
  • SCLX $4.53
  • Resistance Level
  • KLXE $3.00
  • SCLX $5.60
  • Average True Range (ATR)
  • KLXE 0.34
  • SCLX 0.41
  • MACD
  • KLXE -0.03
  • SCLX 0.01
  • Stochastic Oscillator
  • KLXE 15.97
  • SCLX 31.96

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: